COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Three new companies spring to life from boron research at RTP-based Boragen
News | 02. 04. 2022
Boragen
Research Triangle Park-based Boragen to be split into three different companies, one focused on crop protection, one on animal health, and the other on human health.
